Abstract OBJECTIVES: Our goals were to compare the outcome of the intra-atrial lateral tunnel (ILT) and the extracardiac conduit (ECC) techniques for staged total cavopulmonary connection (TCPC) and to compare the current modifications of the TCPC technique, i.e. the prosthetic ILT technique with the current ECC technique with a > _18-mm conduit.
INTRODUCTION
The Fontan operation is the procedure of choice in patients in whom biventricular repair is not feasible [1, 2] . Over the past 30 years, 2 main Fontan techniques have been developed. The intra-atrial lateral tunnel (ILT) technique originally used the right atrial wall (all or part of it) to create a baffle to tunnel the blood from the inferior vena cava directly to the pulmonary arteries [3] [4] [5] . Combined with a connection of the superior vena cava to the pulmonary arteries the total cavopulmonary connection (TCPC) was created [1] . Subsequently, the extracardiac conduit (ECC) technique is described, which uses a conduit from the inferior vena cava to the pulmonary arteries [6] . Over time, the atrial baffle ILT technique has evolved into a prosthetic ILT, in which the intra-atrial tunnel is created using part of a prosthetic tube rather than part of the atrial wall [7] .
Because of haemodynamic advantages and a significant improvement in operative outcomes, the single-stage TCPC has been replaced by a staged approach [8] , which has resulted in relatively low late mortality rates [9, 10] . However, a direct comparison of the long-term outcomes of the 2 TCPC techniques remains difficult due to the limited number of patient-years and due to differences between the duration of follow-up after the 2 TCPC techniques. Furthermore, the ILT and ECC techniques have been updated over time, which further limits up-to-date information on the outcomes of current approaches [11] .
Remarkably, a serial follow-up of TCPC patients has hardly been done. Without this data, and without data on outcome and survival after application of the updated current TCPC techniques, surgeons lack confirmation that these techniques continue to be equally effective in terms of outcome and survival. To address this lack of data, we made use of a previously described cohort of staged ILT or ECC patients in the Netherlands [12] . The updated serial analysis of this cohort had 2 objectives: first, to compare the staged ILT and ECC techniques in terms of outcome and event-free survival after a longer follow-up period; and second, to compare outcome in patients who have undergone TCPC procedures that use the updated ILT or ECC techniques, i.e. to compare the current prosthetic ILT with the current ECC using a large-diameter conduit.
METHODS

Patients
We included all patients who were part of a previously published analysis and who had therefore undergone completion of a staged TCPC with ILT or ECC technique between January 1988 and January 2008. The inclusion and exclusion criteria were published previously [12] . The study complied with the regulations of institutional review boards with regard to retrospective data collection. The local ethics committees approved the retrospective study and waived informed consent.
Definitions
The medical records of all patients were reviewed until September 2017. We recorded all cardiac events during the follow-up until the patient's last visit to the outpatient clinic. The primary end point was death; secondary end points were defined as thromboembolism (TE) that required intervention and/or hospitalization, protein-losing enteropathy, plastic bronchitis, arrhythmias, late reoperations or reinterventions. Arrhythmias were defined as documented bradyarrhythmias or tachyarrhythmias that required intervention and/or hospitalization.
Early complications and mortality were defined as occurring within 30 days after TCPC or before hospital discharge; all other sequelae were considered late. We note that in the previous analysis, we used a different definition of early mortality; the current definition is that of the Society of Thoracic Surgeons Congenital Heart Surgery Database [12, 13] .
Statistical analysis
Continuous variables with a normal distribution (according to the Shapiro-Wilk test) were expressed as mean and standard deviation. Variables with a non-normal distribution were presented as median and interquartile range. Differences between groups were analysed by the Student's t-tests or with the Mann-Whitney U-tests. Categorical variables were presented as numbers and percentages and were evaluated by the v 2 test or the Fisher's exact test.
The incidences of the primary and secondary end points over time were evaluated with the Kaplan-Meier method. Differences in the incidence of end points between the TCPC types were evaluated using the Log-Rank test. Cox proportional hazard analysis was used to determine whether parameters had an influence on the probability of the event. We found no deviations of the proportional hazards assumption by inspecting the plots of log minus log survival functions. A P-value <0.05 was required for a parameter to remain in the multivariable model. All analyses were performed using the SPSS statistical software package version 24.0 (IBM Corp., Armonk, NY, USA). Two-sided P-values <0.05 were considered statistically significant.
RESULTS
A total of 208 patients were included. Patient and surgical characteristics are shown in Table 1 . Hypoplastic left heart syndrome was more common in the ECC group and there was a trend towards more heterotaxy syndrome patients in the ILT group (Table 1) . Further details regarding the patient characteristics have been published previously [12] . In this cohort, the first staged ILT was performed in 1990 and the first staged ECC was performed in 1996. In the patients who underwent ILT, a baffle ILT was used in 51 patients and a prosthetic ILT in 52 patients. In the patients who underwent ECC, the size of the conduit diameter varied, as did the graft material. One patient received a 16-mm Gore-Tex conduit, 17 patients received a 16-mm Vascutek conduit, 33 patients received an 18-mm Gore-Tex conduit and 56 patients received a Gore-Tex conduit with a diameter that was at least 20 mm. Figure 1 shows the change over time in the surgeons' preferences for the different staged TCPC techniques.
The total analysis consisted of 2467 patient-years (1315 ILT, 1152 ECC). The median follow-up duration since TCPC was 13.2 (9.5-16.3) years. The median follow-up durations of the ILT and ECC patients were 15.3 (10.2-18.7) and 12.0 (9.3-14.5) years, P-value <0.001. A total of 9 patients were lost to follow-up; we verified that 7 of these patients were still alive at the end of the follow-up and included them in the analysis for mortality. For the remainder of the analyses, these 9 patients were censored at the time of their last outpatient clinic visit.
Mortality
Overall mortality was 14% (19 ILT, 11 ECC). Kaplan-Meier estimates for overall survival after ILT were 82% at 10 years [standard error (SE) 4%] and 81% at 15 years (SE 4%); after ECC they were 91% at 10 years (SE 3%) and 89% at 15 years (SE 3%) (P = 0.12) (Fig. 2) . For the entire cohort, overall survival at 15 years was 85% (SE 3%). Multivariable analysis revealed the following independent predictors for overall mortality: cardiopulmonary bypass (CPB) time, right ventricle (RV) morphology and the duration of intensive care unit (ICU) stay after TCPC (Table 2) .
Late mortality occurred in 10 ILT and 4 ECC patients, after a median of 38.3 (4.5-91.4) months after TCPC. Causes for late death were Fontan failure in 5, sudden cardiac death in 3, sepsis and multiple organ failure in 1, ventricular fibrillation in 1, thrombus in the systemic RV in 1, bradycardia during surgical closure of the fenestration in 1 and endocarditis in 1 patient; in 1 patient the cause of death was unknown. Kaplan-Meier estimates for late survival after ILT were 90% at 10 years (SE 3%) and 89% at 15 years (SE 3%); after ECC they were 97% at 10 years (SE 2%) and 96% at 15 years (SE 2%) (P = 0.10) (Fig. 2) . Dominant RV was the only predictor in univariable analysis for late mortality [hazard ratio (HR) 3.61, 95% confidence interval (CI) 1.13-11.53;
Although no patients underwent Fontan takedown or heart transplantation, 1 patient was listed for heart transplantation.
Late reinterventions
After TCPC, 140 late reinterventions (surgical and catheter-based) were performed in 84 patients. Late surgical reinterventions accounted for 53 (38%) of all late reinterventions, with 35 patients needing 2 or more late reinterventions. Table 3 shows the types of reinterventions performed after TCPC. In 10 patients, the ECC conduit was replaced. All of these patients had originally received a 16-mm conduit: 1 was a Gore-Tex conduit and the other 9 were Vascutek conduits which are no longer in use [14] .
ILT patients had better Kaplan-Meier estimates for late reintervention-free survival (Fig. 3 ): 75% at 10 years (SE 5%) and 63% at 15 years (SE 6%); for ECC, estimates were 54% at 10 years (SE 5%) and 44% at 15 years (SE 6%) (P = 0.016). Univariable analysis showed that patients were significantly more likely to require late reinterventions if they had an ECC (HR 1.73, 95% CI 1.10-2.71; P = 0.021) or hypoplastic left heart syndrome (HR 2.06, 95% CI 1.25-3.39; P = 0.005). In multivariable analysis, both the ECC technique and hypoplastic left heart syndrome remained independent predictors for late reinterventions during follow-up (HR 1.64, 95% CI 1.04-2.58; P = 0.032 and HR 1.93, 95% CI 1.17-3.20; P = 0.010).
Late arrhythmias
Late arrhythmias occurred in 41 patients (20%) after a median period of 9.9 (5.6-12.4) years after TCPC. Bradyarrhythmia was present in 15 patients, and tachyarrhythmia occurred in 22 patients, one of whom died of ventricular fibrillation. Four patients suffered an out-of-hospital cardiac arrest (3 deaths, 1 survivor with subsequent implantable cardioverter defibrillator (ICD) for secondary prevention) and were suspected of ventricular tachyarrhythmia (no documentation of heart rhythm related to cardiac arrest was available).
Freedom from late arrhythmias was better in ECC patients than in ILT patients (P = 0.034, see Fig. 3 ). Univariable analysis showed that patients were significantly more likely to experience arrhythmia if they had undergone the baffle ILT technique (HR 2.65, 95% CI 1.41-4.97; P = 0.003) or if they had a higher number of post-TCPC procedures (excluding pacemaker procedures; HR 1.57, 95% CI 1.17-2.11; P = 0.003). In multivariable analysis, the baffle ILT technique and the number of post-TCPC interventions remained independent predictors for late arrhythmias during follow-up (Table 2) .
Other events
Other complications were relatively rare: protein-losing enteropathy occurred in a total of 9 patients, 2 in the ILT group and 7 in the ECC group, after a median period of 6.6 (2.8-9.4) years after TCPC; plastic bronchitis was identified in 4 patients, 2 ILT and 2 ECC.
Thromboembolic events occurred in 13 patients (6 ECC and 7 ILT): 2 patients had deep venous thrombosis, 2 patients had a thrombus in the left pulmonary artery, 1 patient had a pulmonary embolism, 1 patient had a transient ischaemic attack, 1 patient had a thrombus in the systemic RV, 1 patient developed a thrombus on a mechanical aortic valve while not taking anticoagulation, 2 patients had chest pain with focal delayed enhancement on magnetic resonance imaging and 2 patients had a cerebral infarction.
No difference in event-free survival between the ILT and ECC groups was found (P = 0.35). At 10-year follow-up, the freedom from any event for all patients was 53% (SE 4%); for ILT this was 59% (SE 5%) and for ECC 46% (SE 5%). At 15 years, freedom from any event for all patients was 39% (SE 4%).
Current total cavopulmonary connection techniques
Since their introduction, both TCPC techniques have been adapted and updated, and this was reflected in the patients in our study: 52 ILT patients had received a prosthetic ILT and 89 ECC patients had received a conduit with a diameter > _18 mm. We considered these 2 subgroups of patients as having been treated with 'current TCPC' techniques. The median follow-up duration of the prosthetic ILT and > _18-mm ECC patients was similar [12.5 (9.4-15.9) years vs 11.0 (9.3-14.5) years, P = 0.12]. For all patients treated with current TCPC techniques, the median follow-up duration post-TCPC was 11.6 (9.3-14.9) years.
The occurrence of late arrhythmias was more frequent in the older baffle ILT group than in the prosthetic ILT group [21 (72%) vs 8 (28%), P = 0.004]. Late arrhythmia-free survival did not differ between the prosthetic ILT and > _18-mm ECC group (P = 0.64, see Fig. 4 ). There were also no differences in late reintervention-free survival between the prosthetic ILT and > _18-mm ECC groups (P = 0.14, see Fig. 4 ). Neither were differences observed in overall survival (P = 0.36) or event-free survival (P = 0.58) between the prosthetic ILT and > _18-mm ECC groups.
DISCUSSION
The results of this study indicate that for the prosthetic ILT technique and the > _18-mm ECC technique currently in use, patients experience no differences in late arrhythmia-free survival and late reintervention-free survival. The 2 groups of patients in this study had a comparable median follow-up duration of 12 years. The long-term follow-up of Fontan patients has been studied extensively. However, many previous studies have included not only TCPC but also older Fontan techniques [9, 15] . In studies that have included TCPC techniques only, a direct comparison of long-term outcomes after the different TCPC procedures is limited by the differences in the duration of follow-up between the ILT and ECC techniques. This difference has been caused by the shift over time towards a preference for the ECC procedure, resulting in relatively higher numbers of older ILT patients [11] .
Survival
Late survival after TCPC was 94% at 10 years and 92% at 15 years. Our figures for late mortality are somewhat lower than the 97% late survival at 10 years post-TCPC in a recently published large cohort [9] . An explanation for this difference could be that their patients were relatively older at TCPC, namely 3.8 years for ILT and 4.8 years for ECC, which may point towards different Results are given as median (IQR) or counts (%). AOV: aortic valve; AVV: atrioventricular valve; ECC: extracardiac conduit; ILT: intra-atrial lateral tunnel; IQR: interquartile range; PM: pacemaker; TCPC: total cavopulmonary connection. selection criteria for eligibility for TCPC than those used in our cohort. In a recent study by Downing et al. [10] , the median age at TCPC was lower, namely 2.3 years, with an overall survival of 92% at 10 years and 88% at 15 years post-TCPC. For patients who survived the first year after TCPC, their survival was similar to that reported here. We observed a trend towards better survival for ECC patients. Two recent meta-analyses have shown a similar trend [11, 16] . However, such a trend was not apparent in the current TCPC modifications in our cohort: patients with a prosthetic ILT and ECC patients with a conduit > _18 mm.
A potential benefit of the ECC is that it gives surgeons the option of performing the TCPC with a shorter CPB time, or even off-pump [16, 17] . However, in our study, ILT patients had a significantly shorter median CPB time. In our study, both the ILT technique and the surgical centre were associated with CPB time. Our multivariable models for overall mortality identified CPB time, duration of ICU stay and RV morphology as independent predictors.
Late reinterventions
Despite relatively good survival, morbidity remains high in Fontan patients [9, 18, 19] . In our cohort, ILT patients had a better freedom from late reinterventions, which was mainly caused by the ECC patients who required replacement of a 16-mm Vascutek conduit. These conduits are no longer in use [14] . Pulmonary artery reinterventions were also more common in the ECC group.
Importantly, comparison of the currently used ECC technique (excluding 16-mm conduits) and the currently used prosthetic ILT technique showed no difference in reintervention-free survival after a medium-term follow-up of similar duration. Internationally available guidelines indicate that reintervention can be considered in selected patients in case of obstruction of systemic or pulmonary venous return, exercise limitation, or unexplained exercise deterioration and fatigue. However, such guidelines rarely provide quantitative limits [20, 21] . As a result, different centres may have different thresholds for reinterventions, and this could have influenced our observations.
Late arrhythmias
Compared with older Fontan cohorts, the burden of arrhythmias is relatively low in our contemporary TCPC population [19] . It has been suggested that ECC is the preferred technique because, theoretically, it minimizes factors that may lead to arrhythmias [17] . In a recent large Fontan study, the incidence of late atrial tachycardia was 7% for ILT and 2% for ECC patients (P < 0.001). However, follow-up duration differed between both techniques (9.2 years for ILT and 4.7 years for ECC; P < 0.001) [22] . In our analysis, we found that late arrhythmia-free survival was better in prosthetic ILT patients than in baffle ILT patients. This was also observed in a recent cross-sectional prospective study conducted by our group [7] . A key finding of our study is that we observed no differences in late arrhythmia-free survival after TCPC between patients who had undergone the current prosthetic ILT technique and those who had undergone the current ECC technique, in a cohort in which the 2 groups had a similar duration of medium-term follow-up.
Other late events
Despite relatively low late mortality, we observed a high number of events, particularly surgical and catheter-based reinterventions. Fifteen-year event-free survival was 39%, with no difference between the entire cohort of ILT and ECC patients. In the Australian-New Zealand cohort that included both TCPC and atriopulmonary connection (APC) patients, freedom from adverse events at 15 years was 59% [9] . This is somewhat better than the percentage found here and is most likely explained by the use of different definitions for adverse events and event-free survival. Clearly not all events have the same impact, demonstrating that improved consensus on outcome measures is required [23] .
Theoretically, ECC patients are more prone to develop TE [1] . Most of our patients were on platelet-aggregation inhibitors or vitamin K antagonists. We observed no differences in the rate of TE between ILT and ECC patients. However, the most severe cases-a thrombus in the systemic chamber, and a sub-total and total occlusion of the left pulmonary artery, conduit and chamber-occurred in ECC patients.
Several other studies have also reported finding no differences in incidence of TE between ILT and ECC patients [24, 25] . The incidence of TE in our cohort was lower than that reported in most other studies and this might be explained by differences in the methods used to identify TE [26] .
Limitations
This is a retrospective study, and although the number of patient-years was comparable, there were more older ILT patients. Another limitation is that our data only covered a follow-up period of 15 years. Future research is therefore required to determine whether the slight outcome differences between the ILT and ECC at the current follow-up duration are still present after a longer duration of follow-up.
CONCLUSIONS
Key findings were the similar rates of late arrhythmia-free survival and late reintervention-free survival in patients undergoing TCPC using the current prosthetic ILT modification and the current ECC technique that uses conduits with a diameter of at least 18 mm. In the entire cohort, no differences were observed in overall or late mortality between the ILT and ECC groups. Although survival was relatively good after staged TCPC, overall event-free survival at 15 years was 39%. 
